133 related articles for article (PubMed ID: 38771994)
61. Representativeness of a Heart Failure Trial by Race and Sex: Results From ASCEND-HF and GWTG-HF.
Greene SJ; DeVore AD; Sheng S; Fonarow GC; Butler J; Califf RM; Hernandez AF; Matsouaka RA; Samman Tahhan A; Thomas KL; Vaduganathan M; Yancy CW; Peterson ED; O'Connor CM; Mentz RJ
JACC Heart Fail; 2019 Nov; 7(11):980-992. PubMed ID: 31606362
[TBL] [Abstract][Full Text] [Related]
62. Characteristics and Medication Use of Psoriasis Patients Who May or May Not Qualify for Randomized Controlled Trials.
Malatestinic W; Nordstrom B; Wu JJ; Goldblum O; Solotkin K; Lin CY; Kistler K; Fraeman K; Johnston J; Hawley LL; Sicignano N; Araujo A
J Manag Care Spec Pharm; 2017 Mar; 23(3):370-381. PubMed ID: 28230450
[TBL] [Abstract][Full Text] [Related]
63. Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual.
Wang YQ; Lv JW; Tang LL; Du XJ; Chen L; Li WF; Liu X; Guo Y; Lin AH; Mao YP; Sun Y; Chen YP; Ma J
Oral Oncol; 2019 Mar; 90():23-29. PubMed ID: 30846172
[TBL] [Abstract][Full Text] [Related]
64. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
[TBL] [Abstract][Full Text] [Related]
65. Data-driven strategies for increasing patient diversity in Bristol Myers Squibb-sponsored US oncology clinical trials.
Kuri L; Setru S; Liu G; Reed DM; Weigand D; Surampudi A; Berger S; Paulucci D; Rai A; Sethuraman V; Vito B; Kellar-Wood H; Balan MM
Clin Trials; 2023 Dec; 20(6):585-593. PubMed ID: 37309819
[TBL] [Abstract][Full Text] [Related]
66. Race and ethnicity do not impact eligibility for remdesivir: A single-center experience.
Pischel L; Walelo M; Benson J; Osborn R; Schrier R; Tuan J; Barakat L; Ogbuagu O
PLoS One; 2021; 16(5):e0250735. PubMed ID: 33956849
[TBL] [Abstract][Full Text] [Related]
67. Evaluation of eligibility and recruitment in breast cancer clinical trials.
Lemieux J; Forget G; Brochu O; Provencher L; Cantin G; Desbiens C; Doyle C; Poirier B; Camden S; Durocher M
Breast; 2014 Aug; 23(4):385-92. PubMed ID: 24679829
[TBL] [Abstract][Full Text] [Related]
68. Generalizability of Blood Pressure Lowering Trials to Older Patients: Cross-Sectional Analysis.
Sheppard JP; Lown M; Burt J; Temple E; Lowe R; Ashby H; Todd O; Allen J; Ford GA; Fraser R; Heneghan C; Hobbs FDR; Jowett S; Little P; Mant J; Mollison J; Payne R; Williams M; Yu LM; McManus RJ
J Am Geriatr Soc; 2020 Nov; 68(11):2508-2515. PubMed ID: 32898307
[TBL] [Abstract][Full Text] [Related]
69. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.
Magnuson A; Bruinooge SS; Singh H; Wilner KD; Jalal S; Lichtman SM; Kluetz PG; Lyman GH; Klepin HD; Fleury ME; Hirsch B; Melemed A; Arnaldez FI; Basu Roy U; Schenkel C; Sherwood S; Garrett-Mayer E
Clin Cancer Res; 2021 May; 27(9):2424-2429. PubMed ID: 33563633
[TBL] [Abstract][Full Text] [Related]
70. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group.
Uldrick TS; Ison G; Rudek MA; Noy A; Schwartz K; Bruinooge S; Schenkel C; Miller B; Dunleavy K; Wang J; Zeldis J; Little RF
J Clin Oncol; 2017 Nov; 35(33):3774-3780. PubMed ID: 28968173
[TBL] [Abstract][Full Text] [Related]
71. A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316).
Javid SH; Unger JM; Gralow JR; Moinpour CM; Wozniak AJ; Goodwin JW; Lara PN; Williams PA; Hutchins LF; Gotay CC; Albain KS
Oncologist; 2012; 17(9):1180-90. PubMed ID: 22723506
[TBL] [Abstract][Full Text] [Related]
72. Characteristics of clinical trials that require participants to be fluent in English.
Egleston BL; Pedraza O; Wong YN; Dunbrack RL; Griffin CL; Ross EA; Beck JR
Clin Trials; 2015 Dec; 12(6):618-26. PubMed ID: 26152834
[TBL] [Abstract][Full Text] [Related]
73. Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke.
Bress AP; Tanner RM; Hess R; Gidding SS; Colantonio LD; Shimbo D; Muntner P
J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27405811
[TBL] [Abstract][Full Text] [Related]
74. Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
Fujimoto D; Morimoto T; Tamiya M; Hata A; Matsumoto H; Nakamura A; Yokoyama T; Taniguchi Y; Uchida J; Sato Y; Yokoi T; Tanaka H; Furuya N; Masuda T; Sakata Y; Miyauchi E; Hara S; Saito G; Miura S; Kanazu M; Yamamoto N; Akamatsu H
JAMA Netw Open; 2023 Feb; 6(2):e230698. PubMed ID: 36826813
[TBL] [Abstract][Full Text] [Related]
75. Eligibility of patients with chronic obstructive pulmonary disease for inclusion in randomised control trials investigating triple therapy: a study using routinely collected data.
Whittaker HR; Torkpour A; Quint J
Respir Res; 2024 Jan; 25(1):43. PubMed ID: 38238769
[TBL] [Abstract][Full Text] [Related]
76. The value of structured data elements from electronic health records for identifying subjects for primary care clinical trials.
Ateya MB; Delaney BC; Speedie SM
BMC Med Inform Decis Mak; 2016 Jan; 16():1. PubMed ID: 26754574
[TBL] [Abstract][Full Text] [Related]
77. Effect of prior cancer on survival of hepatocellular carcinoma: implications for clinical trial eligibility criteria.
Sun X; Li L; Xu L; Zhou Z; Chen J; Wang J; Zhang Y; Hu D; Chen M
BMC Cancer; 2021 Feb; 21(1):147. PubMed ID: 33563246
[TBL] [Abstract][Full Text] [Related]
78. Evolution in the eligibility criteria of randomized controlled trials for systemic cancer therapies.
Srikanthan A; Vera-Badillo F; Ethier J; Goldstein R; Templeton AJ; Ocana A; Seruga B; Amir E
Cancer Treat Rev; 2016 Feb; 43():67-73. PubMed ID: 26827694
[TBL] [Abstract][Full Text] [Related]
79. Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity.
Garcia S; Bisen A; Yan J; Xie XJ; Ramalingam S; Schiller JH; Johnson DH; Gerber DE
J Thorac Oncol; 2017 Oct; 12(10):1489-1495. PubMed ID: 28802905
[TBL] [Abstract][Full Text] [Related]
80. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
